Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12–49.
Google Scholar
Kasper S, Sebastian M. The pharmacologic inhibition of KRAS mutants as a treatment for cancer: therapeutic principles and clinical results. Dtsch Arztebl Int. 2025;122:163–7.
Wolf E, Sacchi de Camargo Correia G, Li S, Zhao Y, Manochakian R, Lou Y. Emerging immunotherapies for advanced non-small-cell lung cancer. Vaccines (Basel). 2025;13:128.
Salem A, Asselin MC, Reymen B, Jackson A, Lambin P, West CML, et al. Targeting hypoxia to improve non-small cell lung cancer outcome. J Natl Cancer Inst. 2018;110:14–30.
Yip C, Blower PJ, Goh V, Landau DB, Cook GJ. Molecular imaging of hypoxia in non-small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2015;42:956–76.
Google Scholar
Infantino V, Santarsiero A, Convertini P, Todisco S, Iacobazzi V. Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target. Int J Mol Sci. 2021;22:5703.
Kierans SJ, Taylor CT. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology. J Physiol. 2021;599:23–37.
Google Scholar
Okoye CN, Koren SA, Wojtovich AP. Mitochondrial complex I ROS production and redox signaling in hypoxia. Redox Biol. 2023;67:102926.
Google Scholar
Poole LP, Macleod KF. Mitophagy in tumorigenesis and metastasis. Cell Mol Life Sci. 2021;78:3817–51.
Google Scholar
Wu H, Chen Q. Hypoxia activation of mitophagy and its role in disease pathogenesis. Antioxid Redox Signal. 2015;22:1032–46.
Google Scholar
Han R, Liu Y, Li S, Li XJ, Yang W. PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models. Autophagy. 2023;19:1396–405.
Google Scholar
Zaman M, Shutt TE. The role of impaired mitochondrial dynamics in MFN2-mediated pathology. Front Cell Dev Biol. 2022;10:858286.
Google Scholar
Ham SJ, Lee D, Yoo H, Jun K, Shin H, Chung J. Decision between mitophagy and apoptosis by Parkin via VDAC1 ubiquitination. Proc Natl Acad Sci USA. 2020;117:4281–91.
Google Scholar
Wang J, Qiu Y, Yang L, Wang J, He J, Tang C, et al. Preserving mitochondrial homeostasis protects against drug-induced liver injury via inducing OPTN (optineurin)-dependent Mitophagy. Autophagy. 2024;20:2677–96.
Google Scholar
Mu N, Wang Y, Li X, Du Z, Wu Y, Su M, et al. Crotonylated BEX2 interacts with NDP52 and enhances mitophagy to modulate chemotherapeutic agent-induced apoptosis in non-small-cell lung cancer cells. Cell Death Dis. 2023;14:645.
Google Scholar
Li X, Tie J, Sun Y, Gong C, Deng S, Chen X, et al. Targeting DNM1L/DRP1-FIS1 axis inhibits high-grade glioma progression by impeding mitochondrial respiratory cristae remodeling. J Exp Clin Cancer Res. 2024;43:273.
Google Scholar
van der Laan M, Horvath SE, Pfanner N. Mitochondrial contact site and cristae organizing system. Curr Opin Cell Biol. 2016;41:33–42.
Google Scholar
Pinero-Martos E, Ortega-Vila B, Pol-Fuster J, Cisneros-Barroso E, Ruiz-Guerra L, Medina-Dols A, et al. Disrupted in schizophrenia 1 (DISC1) is a constituent of the mammalian mitochondrial contact site and cristae organizing system (MICOS) complex, and is essential for oxidative phosphorylation. Hum Mol Genet. 2016;25:4157–69.
Google Scholar
Wollweber F, von der Malsburg K, van der Laan M. Mitochondrial contact site and cristae organizing system: A central player in membrane shaping and crosstalk. Biochim Biophys Acta Mol Cell Res. 2017;1864:1481–9.
Google Scholar
Tang J, Zhang K, Dong J, Yan C, Hu C, Ji H, et al. Sam50-Mic19-Mic60 axis determines mitochondrial cristae architecture by mediating mitochondrial outer and inner membrane contact. Cell Death Differ. 2020;27:146–60.
Google Scholar
Teresak P, Lapao A, Subic N, Boya P, Elazar Z, Simonsen A. Regulation of PRKN-independent mitophagy. Autophagy. 2022;18:24–39.
Google Scholar
Meng Z, Cheng S, Wang W, Wei Z, Guo Z, Zhao X, et al. Up-regulation of MIC19 promotes growth and metastasis of hepatocellular carcinoma by activating ROS/NF-kappaB signaling. Transl Oncol. 2024;42:101906.
Google Scholar
Zhao C, Xu Z, Que H, Zhang K, Wang F, Tan R, et al. ASB1 inhibits prostate cancer progression by destabilizing CHCHD3 via K48-linked ubiquitination. Am J Cancer Res. 2024;14:3404–18.
Google Scholar
Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18:157.
Google Scholar
Latorre-Muro P, O’Malley KE, Bennett CF, Perry EA, Balsa E, Tavares CDJ, et al. A cold-stress-inducible PERK/OGT axis controls TOM70-assisted mitochondrial protein import and cristae formation. Cell Metab. 2021;33:598–614.e7.
Google Scholar
Yang Y, Owusu FB, Wu H, Zhang X, Li R, Liu Z, et al. Mitochondria as therapeutic targets for natural products in the treatment of cardiovascular diseases. J Ethnopharmacol. 2025;45:119588.
Darshi M, Mendiola VL, Mackey MR, Murphy AN, Koller A, Perkins GA, et al. ChChd3, an inner mitochondrial membrane protein, is essential for maintaining crista integrity and mitochondrial function. J Biol Chem. 2011;286:2918–32.
Google Scholar
Rajala RV, Datla RS, Moyana TN, Kakkar R, Carlsen SA, Sharma RK. N-myristoyltransferase. Mol Cell Biochem. 2000;204:135–55.
Google Scholar
Prasad KK, Toraskar MP, Kadam VJ. N-myristoyltransferase: a novel target. Mini Rev Med Chem. 2008;8:142–9.
Google Scholar
Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721–32.
Google Scholar
Lee SH, Golinska M, Griffiths JR HIF-1-Independent mechanisms regulating metabolic adaptation in hypoxic cancer cells. Cells. 2021;10:2357.
Chen T, Chen X, Zhang S, Zhu J, Tang B, Wang A, et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genomics Proteomics Bioinformatics. 2021;19:578–83.
Google Scholar
Members C-N, Partners. Database resources of the national genomics data center, China National Center for Bioinformation in 2024. Nucleic Acids Res. 2024;52:D18–D32.
Google Scholar
